Mesenchymal Stem Cells in Critical Limb Ischemia

NCT00883870 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia

Interventions

DRUG: mesenchymal stem cells
DRUG: Plasmalyte A

Sponsor

Stempeutics Research Pvt Ltd